mk

@RNArelics

New York, NY
Vrijeme pridruživanja: rujan 2018.
1 fotografija ili videozapis Fotografije i videozapisi

Tweetovi

Blokirali ste korisnika/cu @RNArelics

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @RNArelics

  1. proslijedio/la je Tweet
    prije 20 sati

    Yescarta sales

    7 replies 10 proslijeđenih tweetova 27 korisnika označava da im se sviđa
    Poništi
  2. proslijedio/la je Tweet
    4. velj

    Gilead preparing a trial in China of remdesivir to treat 2019-nCoV: . Meanwhile, at least 9 trials of #2019-nCoV therapies are underway. All BioCentury coverage of the outbreak is in front of the paywall at .

    56 proslijeđenih tweetova 87 korisnika označava da im se sviđa
    Poništi
  3. proslijedio/la je Tweet
    29. sij

    And here is a sample of 3 policies we describe and how they alter the Reward Box shape and thus the risk and reward of developing particular types of drugs:

    1 reply 6 proslijeđenih tweetova 8 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  4. proslijedio/la je Tweet
    30. sij

    Number of patients treated w/ CAR-Ts in Europe (commercial vs academic)

    2 proslijeđena tweeta 7 korisnika označava da im se sviđa
    Poništi
  5. proslijedio/la je Tweet
    30. sij

    A prime example of a great explainer for a complex topic: my brilliant friend , aka Gene Editor, explains genome editing and search-and-replace (prime) editing re:

    1 reply 95 proslijeđenih tweetova 216 korisnika označava da im se sviđa
    Poništi
  6. proslijedio/la je Tweet
    29. sij

    Matthew Disney is talking about how to approach RNA as a target for small-molecule probes and drugs at - here's a perspective with more on this topic

    1 reply 10 proslijeđenih tweetova 34 korisnika označavaju da im se sviđa
    Poništi
  7. proslijedio/la je Tweet
    28. sij

    Humira biosimilars now controlling almost 40% of the market in the EU, according to Bernstein. The UK and Germany are outpacing the others... ...and the US looks on in shame, swallowing another 7.4% price increase from AbbVie for 2020

    16 proslijeđenih tweetova 37 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  8. proslijedio/la je Tweet
    28. sij

    Biosimilar competition update: is launching its 3 at WAC list prices of -22% to -24% below competitors' products Open question: Will , , and embrace or block lower price ?

    11 proslijeđenih tweetova 15 korisnika označava da im se sviđa
    Poništi
  9. proslijedio/la je Tweet
    28. sij

    The FDA finalized 6 guidance documents on development about: - - - Retinal disorders - CMC for INDs - LT follow-up - Retrovirus testing Also released new draft guidance on interpreting the sameness of gene therapies.

    1 reply 8 proslijeđenih tweetova 12 korisnika označava da im se sviđa
    Poništi
  10. proslijedio/la je Tweet
    28. sij

    I can see how this makes it a lot easier to read. Thank you for assembling.

    If you are looking to understand the crux of the drug pricing debate, look no further than this excellent/logical post from :
    1 proslijeđeni tweet 16 korisnika označava da im se sviđa
    Poništi
  11. proslijedio/la je Tweet
    26. sij

    Kobe was a legend on the court and just getting started in what would have been just as meaningful a second act. To lose Gianna is even more heartbreaking to us as parents. Michelle and I send love and prayers to Vanessa and the entire Bryant family on an unthinkable day.

    17.211 replies 692.411 proslijeđenih tweetova 4.149.291 korisnik označava da mu se sviđa
    Poništi
  12. proslijedio/la je Tweet
    26. sij

    Given there will be a big need for many biotech's to raise this year & January 2020 broke an all-time record for total amount raised & # of Co's that raised in Jan, I put together a list (far from perfect) of bio companies that have < 2 years of cash based on estimates.

    26 proslijeđenih tweetova 84 korisnika označavaju da im se sviđa
    Poništi
  13. proslijedio/la je Tweet
    22. sij

    Woodcock to Unger to Stein, or how scored its FDA double play. Via

    7 proslijeđenih tweetova 7 korisnika označava da im se sviđa
    Poništi
  14. proslijedio/la je Tweet
    22. sij

    Neutrophils as emerging therapeutic targets in infection, pulmonary diseases, cardiovascular diseases, inflammatory disorders and cancer - a new review published today

    10 proslijeđenih tweetova 19 korisnika označava da im se sviđa
    Poništi
  15. proslijedio/la je Tweet
    22. sij

    Very underwhelming data for anti-CD47 magrolimab + cetuximab combo in colorectal cancer 6.7% (2/30) ORR in KRAS wild type CRC 0% (0/40) ORR in KRAS mutant CRC

    12 proslijeđenih tweetova 50 korisnika označava da im se sviđa
    Poništi
  16. proslijedio/la je Tweet
    17. sij

    Loved this story from -- At , two CEOs, two radically different therapies, and a fight to chase down sickle cell

    1 reply 4 proslijeđena tweeta 16 korisnika označava da im se sviđa
    Poništi
  17. proslijedio/la je Tweet
    13. sij

    Just amazing people are still falling for these "response" from their miracle sextuple combo How the hell do you run a controlled trial to convince FDA about the real effect of your drug?

    16 replies 15 proslijeđenih tweetova 74 korisnika označavaju da im se sviđa
    Poništi
  18. proslijedio/la je Tweet
    16. sij

    Three important new papers today demonstrate that the presence of B cells in tertiary lymphoid structures (TLS) is associated with a favorable response to cancer

    26 proslijeđenih tweetova 97 korisnika označava da im se sviđa
    Poništi
  19. proslijedio/la je Tweet
    15. sij

    Our NEW Review by Vishwakarma & Piddini discusses how cell competition between tumour cells & neighbouring epithelial host cells may dictate tumorigenesis & proposes manipulating cell competition as an orthogonal therapeutic strategy

    44 proslijeđena tweeta 110 korisnika označava da im se sviđa
    Poništi
  20. proslijedio/la je Tweet
    15. sij

    This Is Our Cells Under Pressure: Decreased DNA Damage Repair in Response to Targeted Therapies Facilitates the Emergence of Drug-Resistant Clones

    38 proslijeđenih tweetova 71 korisnik označava da mu se sviđa
    Poništi

@RNArelics još nije objavio nijedan Tweet.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·